Diabetes & Endocrinology News

• Tandem Insulin Pump System Integrates With Libre Sensor Tandem Diabetes Care's t:slim X2 insulin pump becomes the first to integrate with Abbott's FreeStyle Libre 2 Plus Sensor for US users.
  Medscape Medical News, January 08, 2024
• Study Identifies CV Comorbidities Linked to Dermatomyositis The results "represent potential areas for preventative intervention," the researchers wrote.
  Medscape Medical News, January 08, 2024
• New Tool May Offer Diagnostic Edge for Diabetic Neuropathy Researchers adapted optical diffusion technology in a low-cost portable device to assess microvascular blood flow in human skin and showed proof of concept in early detection of diabetic neuropathy.
  Medscape Medical News, January 08, 2024
• SGLT2 Inhibitors Begin to Show Potential in Rheumatology Sodium-glucose cotransporter-2 inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs of benefits in these conditions.
  MDedge News, January 08, 2024
• Intermittent Energy Restriction Tied to Gut, Brain Changes Losing weight via intermittent energy restriction can curb brain activity related to eating behavior and increase microbial diversity in the gut in individuals with obesity.
  Medscape Medical News, January 08, 2024
• Eli Lilly Offers Obesity Drug Directly to Consumers Eli Lilly launched its direct-to-patient portal on Thursday, providing its obesity medicine (as well as diabetes and migraine drugs) direct to the consumer.
  WebMD Health News, January 05, 2024
• Are Post-Meal Insulin Surges Beneficial? Contrary to reports of negative effects, postprandial insulin spikes are associated with improvements in a longitudinal study.
  Medscape Medical News, January 05, 2024
• FDA Evaluating 3 Side Effects Reported for Weight Loss Drugs A new report listed potential links between GLP-1 agonists and alopecia, aspiration during surgery, and suicidal ideation.
  WebMD Health News, January 05, 2024
• The Struggle to Provide Gender-Affirming Care to Youth Major medical groups object to state restrictions on gender-affirming medical care. Politicization has sparked threats against clinicians and drawn interest from lawmakers.
  Medscape Medical News, January 05, 2024
• Wegovy, Ozempic Not Linked to Increase in Suicidal Thoughts, US Study Finds A large U.S. study found no evidence that taking Novo Nordisk's Ozempic or Wegovy is tied to an increase in suicidal thoughts, researchers reported on Friday.
  Reuters Health Information, January 05, 2024
• Merck Seeks GLP-1 Drugs With Benefits Beyond Weight Loss - CEO Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.
  Reuters Health Information, January 04, 2024
• Lilly Launches Website, Home Delivery Option for Weight-loss Drug Eli Lilly and Co on Thursday launched a website to enable people to directly order from the drugmaker including its weight-loss medicine Zepbound as well as connect people...
  Reuters Health Information, January 04, 2024
• Wegovy Maker Novo Nordisk Enters Research Tie-ups With US Biotech Firms Blockbuster weight-loss drug maker Novo Nordisk announced on Thursday research collaborations with two U.S. biotech firms, part of its efforts to stay ahead in big pharma's...
  Reuters Health Information, January 04, 2024
• Pediatric Obesity Specialists Struggle to Get GLP-1s The medications can reduce or eliminate weight-related complications in children but are in short supply, and insurers are denying coverage, said pediatricians.
  Medscape Medical News, January 03, 2024
• Digital Assistant Helps Ease an Overactive Bladder A digital tool may represent a more accessible and less expensive alternative to pelvic floor therapy.
  Medscape Medical News, January 03, 2024
• Artificial Sweeteners Alter the Duodenal Microbiome Nonsugar sweeteners affected the stool and small bowel microbiomes differently, and the type of sweetener consumed proved relevant to which microbiome changes occurred.
  Medscape Medical News, January 03, 2024
• Extreme Heat and Hypoglycemia Risk in Older Insulin Users In a large study on older adults with diabetes on insulin in the United States and Taiwan, exposure to higher heat and humidity was associated with an increased risk for serious hypoglycemic events.
  Medscape Medical News, January 02, 2024
• Weight-loss Drugs: Who, and What, Are They Good For? Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to...
  Reuters Health Information, January 02, 2024
• Explainer-What Other Health Conditions Might Weight-loss Drugs Treat? Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.
  Reuters Health Information, January 02, 2024
• Drugmakers Set to Raise US Prices on 500 Drugs in January Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed...
  Reuters Health Information, December 29, 2023
• Top 10 Fictional Docs on Streaming TV Both tried-and-true and out-of-the-ordinary holiday gift ideas are offered to those seeking a great present for a physician.
  Medscape News Slideshows, December 15, 2023
• Rivals Explore Booming Weight-Loss Drug Market Entry Novo Nordisk and Eli Lilly have pulled ahead in the race for a slice of the weight-loss drugs market, expected to be worth $100 billion by the end of the decade.
  Reuters Health Information, December 08, 2023
• Eli Lilly Obesity Drug Now Available in US Pharmacies
  Reuters Health Information, December 05, 2023
• Roche Joins Race for Obesity Drugs With $2.7 Billion Carmot Deal Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk and Eli Lilly.
  Reuters Health Information, December 04, 2023
• Reducing Albumin Improves Kidney and Heart Function The tablet drug finerenone significantly reduces kidney risk in people with type 2 diabetes and also protects heart health, researchers found.
  Medscape Medical News, December 04, 2023
• Statin Use Remains Low for At-Risk Patients Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease.
  Medscape Medical News, December 04, 2023
• No Benefit of Levothyroxine in Heart Donors New data challenge the common practice of levothyroxine administration in potential heart donors after brain death to preserve heart function and make more hearts available for transplantation.
  Medscape Medical News, December 04, 2023
• How Gender-Affirming Treatment Affects Erythrocytosis Gender-affirming hormone therapy has been associated with a risk for abnormal blood cell elevation, but a new study finds that it is a lower risk than was previously believed.
  Medscape Medical News, December 04, 2023
• US Obesity Docs Expect Zepbound to Show Heart Benefit Some leading US obesity specialists say they expect Eli Lilly’s powerful weight-loss drug Zepbound will produce the same or similar heart benefits as Novo Nordisk’s popular Wegovy.
  Reuters Health Information, December 01, 2023
• Launches of Novo Nordisk's Weight-Loss Drug Wegovy Novo Nordisk is pushing ahead with the launches of weight-loss drug Wegovy in Europe and Asia, even as it struggles to keep up with demand.
  Reuters Health Information, December 01, 2023
• EU Watchdog Seeks More Safety Data From GLP-1 Drugmakers The EU's drug watchdog will request more data from makers of a class of diabetes and weight-loss drugs including Ozempic and Wegovy to further investigate suicidal thoughts in some patients taking them.
  Reuters Health Information, December 01, 2023
• Pfizer Drops Twice-Daily Version of Obesity Pill Over Side Effects Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients dropped out of its midstage trial with high rates of side effects such as nausea and vomiting.
  Reuters Health Information, December 01, 2023
• Smoking Alters Salivary Microbiota Changes in oral microbiota caused by cigarette smoking could contribute to development of chronic health conditions.
  Medscape Medical News, December 04, 2023
• Procedures May Ease Postmenopausal Pain Better Than Drugs Postmenopausal women report more significant improvements in chronic pain after procedural interventions when compared with their younger counterparts, despite being notably less likely to use muscle relaxants, TCAs, and benzodiazepines.
  Medscape Medical News, December 01, 2023
• What Is the Dark Side of GLP-1 Receptor Agonists? Doctors who prescribe this class of medication should be aware of the rare side effects with which it is associated, said an obesity expert.
  Medscape Medical News, December 01, 2023
• Novo Nordisk Finds Compounded Wegovy Up to 33% Impure Novo Nordisk on Thursday said it sued one compounding pharmacy and refiled a lawsuit against another after finding their products claiming to contain the active ingredient for its in-demand weight-loss drug were impure.
  Reuters Health Information, November 30, 2023
• Late-Life Increases in Pulmonary Pressure, Hypertension Age-related increases in pulmonary artery systolic pressure occur in concert with worsening left ventricular diastolic dysfunction and contribute to late-life dyspnea, new data show.
  Medscape Medical News, November 30, 2023
• ACG 2023 Low-Dose Aspirin: No Flares in Pregnant Patients With IBD Low-dose aspirin is recommended for pregnant women who are at risk of hypertensive disorders, such as eclampsia, preeclampsia, and gestational diabetes.
  MDedge News, November 29, 2023
• DMARDs Linked to Reduced Thyroid Disease Incidence In a large Swedish rheumatoid arthritis cohort, the incidence of thyroid disease declines after RA diagnosis vs the general population, with the effect strongest among those treated with anti-rheumatic drugs.
  Medscape Medical News, November 29, 2023
• More Weight Loss With Mounjaro Than Ozempic: Data Analysis Overweight or obese adults lost more weight and shed pounds faster using Eli Lilly's Mounjaro than those taking Novo Nordisk's popular rival weight loss drug.
  Reuters Health Information, November 27, 2023